November 13, 2024—R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE ... eluting bioresorbable scaffold for treating below-the-knee (BTK) peripheral ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...

Impaired blood circulation in the lower limbs is a common health problem among the elderly and one of the most prominent ...

The diversion of blood flow through arterialization of the deep veins in the foot holds up well at 2 years as a therapy for ...

VANCOUVER, BC, Nov. 6, 2024 /PRNewswire/ - Vascular access is a dynamic market, brimming with innovative devices that make accessing veins and arteries easier, safer, and more effective than ever.

Endologix announced final 36-month results for the DETOUR2 study evaluating its Detour system for treating peripheral ...

Interventional cardiologist Dr. Ross Melvin joins us to give a demonstration of the new technology available to treat peripheral arterial disease.

Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...

The ELEGANCE registry, which is focused on historically underrepresented minorities and women, analyzed endovascular treatment ...